EXOLENS
Live / Applied — Extension of time to oppose received (as of 11 Dec 2025)
What this means for you
Not registered yet, but its 11 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99037289
- Mark type
- Stylized text
- Filed
- 11 Feb 2025
- Published for opposition
- 11 Nov 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific and medical research and development in the field of computational biology, bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; temporary use of online, non-downloadable software for drug development, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in the nature of a drug discovery platform, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in the nature of a diagnostic platform used to isolate, fractionate, and interrogate cells as diagnostics; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and therapeutics; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for cellular diagnostic and research services; platform as a service (PAAS) featuring computer software platforms for cellular isolation and analysis; platform as a service (PAAS) featuring computer software platforms to isolate, fractionate, and interrogate cells as diagnostics; all of the foregoing excluding optics and electro-optics and related services
Owner
- Flagship Labs 103, Inc., Cambridge, MA, US
- Flagship Labs 103, Inc., Cambridge, MA, US
Prosecution history
- 26 Mar 2026 — POST PUBLICATION AMENDMENT - ENTERED
- 23 Mar 2026 — ASSIGNED TO PETITION STAFF
- 26 Jan 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 11 Dec 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 11 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Nov 2025 — PUBLISHED FOR OPPOSITION
- 05 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jul 2025 — NON-FINAL ACTION E-MAILED
- 21 Jul 2025 — NON-FINAL ACTION WRITTEN
- 20 Jul 2025 — ASSIGNED TO EXAMINER